You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

94 Results
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Intent: Palliative
Funding:
ODB - General Benefit
    capecitabine
Jan 2024
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Intent: Palliative
Jan 2024
Drug
Other Name(s): Rylaze™
Jan 2024
Guidelines and Advice
Status: In-Review
ID: 19-4
May 2015
Guidelines and Advice
Jan 2015
Guidelines and Advice
Guidelines and Advice
Jun 2015

Pages